2-isopropyl-1-((4-(3-(N-methyl-N-(3,4-dimethoxy-beta-phenethyl)amino)propoxy)benzenesulfonyl))indolizine,
fantofarone,
SR 33557,
SR-33557,
Fantofarone,
114432-13-2,
SR-33557,
Fantofaronum [INN-Latin],
Fantofarona [INN-Spanish],
UNII-KU213XYO69,
SR 33557,
KU213XYO69,
sr33557,
3,4-Dimethoxy-N-methyl-N-(3-(4-((2-(1-methylethyl)-1-indolizinyl)sulfonyl)phenoxy)propyl)benzeneethanmine,
Fantofarona,
Fantofaronum,
1-((p-(3-((3,4-Dimethoxyphenethyl)methylamino)propoxy)phenyl)sulfonyl)-2-isopropylindolizine,
Benzeneethanamine, 3,4-dimethoxy-N-methyl-N-(3-(4-((2-(1-methylethyl)-1-indolizinyl)sulfonyl)phenoxy)propyl)-,
Benzeneethanamine, 3,4-dimethoxy-N-methyl-N-[3-[4-[[2-(1-methylethyl)-1-indolizinyl]sulfonyl]phenoxy]propyl]-,
N-(3,4-dimethoxyphenethyl)-3-(4-((2-isopropylindolizin-1-yl)sulfonyl)phenoxy)-N-methylpropan-1-amine,
Fantofarone [BAN:INN],
Fantofarone [INN:BAN],
C31H38N2O5S,
AC1L3ON8,
SCHEMBL77818,
CHEMBL285855,
DTXSID30150729,
EX-A1900,
ZINC4215990,
BDBM50101905,
LS-30117,
HY-105117,
CS-0025047,
2-isopropyl-1-((4-(3-(N-methyl-N-(3,4-dimethoxy-beta-phenethyl)amino)propoxy)benzenesulfonyl))indolizine,
N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methyl-3-[4-(2-propan-2-ylindolizin-1-yl)sulfonylphenoxy]propan-1-amine,
C31-H38-N2-O5-S,
CID119349,
N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methyl-3-[4-(2-propan-2-y,